Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | SWIB complex protein | 0.0045 | 0.7314 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0045 | 0.7314 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.4915 | 0.4915 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0045 | 0.7314 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0045 | 0.7314 | 0.7314 |
Brugia malayi | brahma associated protein 60 kDa | 0.0045 | 0.7314 | 0.7314 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0045 | 0.7314 | 0.7314 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 1 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0045 | 0.7314 | 0.7314 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0052 | 0.915 | 0.915 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0045 | 0.7314 | 0.7314 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0045 | 0.7314 | 0.7314 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.4915 | 0.4915 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0045 | 0.7314 | 0.7314 |
Plasmodium vivax | hypothetical protein, conserved | 0.0045 | 0.7314 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.915 | 0.915 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0045 | 0.7314 | 0.7314 |
Loa Loa (eye worm) | brahma associated protein | 0.0045 | 0.7314 | 0.7314 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0045 | 0.7314 | 0.7314 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.4915 | 0.4915 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0045 | 0.7314 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0052 | 0.915 | 0.915 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0045 | 0.7314 | 0.7314 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0045 | 0.7314 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0045 | 0.7314 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0052 | 0.915 | 0.915 |
Brugia malayi | brahma associated protein 60 kDa | 0.0045 | 0.7314 | 0.7314 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0045 | 0.7314 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0045 | 0.7314 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 1 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.0045 | 0.7314 | 0.7314 |
Schistosoma mansoni | hypothetical protein | 0.0045 | 0.7314 | 0.7314 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 1 | 1 |
Onchocerca volvulus | 0.0045 | 0.7314 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0045 | 0.7314 | 0.7314 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.